NSE
Wockhardt LimitedWOCKPHARMA
Wockhardt Limited is an NSE-listed company (WOCKPHARMA).
AI-generated overview — verify before relying on it.
Net institutional flow
No institutional deals
Institutional buyers
0 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | ACUTAAS | +₹98.2 Cr | 1 | — | — | +4 | 6 |
| 2 | WOCKPHARMAThis | +₹0 Cr | 2 | — | — | +4 | 6 |
| 3 | ACMESOLAR | — | — | — | — | +3 | 6 |
| 4 | AADHARHFC | — | — | — | — | — | — |
| 5 | AARTIIND | — | — | — | — | — | — |
| 6 | ACE | +₹0 Cr | 2 | — | — | — | — |
| 7 | AAVAS | −₹1.9 Cr | 2 | — | — | — | — |
| 8 | ABFRL | −₹142.6 Cr | 4 | — | — | — | — |
| 9 | ABLBL | −₹314.4 Cr | 29 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
- 2026-06-11FilingPursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations andDisclosure ReqInvestor Call
- 2026-05-29NewsWockhardt Shares Jump 11% After CDSCO Approves New AntibioticEquitypandit
- 2026-05-11NewsWockhardt's (NSE:WOCKPHARMA) Strong Earnings Are Of Good Qualitysimplywall.st
- 2026-05-06BulkBUY · ₹173.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-05-06BulkSELL · ₹173.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-05-06NetDay net −₹0.1 Cr
- 2026-04-18NewsWockhardt Limited Announces Special Window for Physical Share Transfer Re-lodgmentscanx.trade
- 2026-01-03NewsWhile individual investors own 34% of Wockhardt Limited (NSE:WOCKPHARMA), private companies are its largest shsimplywall.st
- 2025-12-01NewsWockhardt Share Price Surge 18% as US FDA Accepts NDA for ZaynichHDFC Sky
- 2025-12-01NewsWhy Are Wockhardt Shares Rising Today? BSE 500 Pharma Stock Jumps 20% After USFDA’s BIG UpdateGoodreturns
Merged from deals, filings, corporate actions and news — newest first. Compact rolls each day up to net flow + counts. Scope with the range above.
Filings that matter
- 3Investor CallNeutral
2015, as amended and in continuation to our letter bearing reference no.
Source PDF →
2 deals · 2026-05-06 → 2026-05-06
| Date | Counterparty | Type | Side | Value |
|---|---|---|---|---|
| 2026-05-06 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | BUY | ₹173.7 Cr |
| 2026-05-06 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | SELL | ₹173.7 Cr |
2 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
Results & transcripts
Financial results
None yet.
News & chatter on WOCKPHARMA
RSS News
6▲Equitypandit · 29/5/2026
▲simplywall.st · 11/5/2026
scanx.trade · 18/4/2026
simplywall.st · 3/1/2026
▲HDFC Sky · 1/12/2025
▲Goodreturns · 1/12/2025
Google News RSS — links open the source.
Investdesk
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.